Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Spots to Go Hang Floating - 2Israeli president concerned over proposed renaming of park
- 3Turning into a Sharp Financial backer: Individual budget Wins
- 4Why is everyone talking about Paul Dano? George Clooney becomes the actor's latest defender in this 'time of cruelty.'
- 5From Amateur to Master: My Involvement in Photography
- Different Film Classification: What's Your Go-To for Amusement
- Pick Your #1 Kind Of Treat
- 15 Preposterous Cosplay Ensembles That Will Blow You Away
- New Year's Eve Live: Nashville's Big Bash: How to watch the star-studded country music special live
- 7 Well known Vacation spots In The US
- Building a Flourishing Business: Illustrations from Business people
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- NAFFIC, AWARE claim first China-EU DPP for textiles
- Spain's Easter processions draw more tourists amid Iran war
